ROWNAK AFROZ: Open Payments
NPI 1497963839 · INDIO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$640 in 11 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $412 · 2025 $640
Food & beverage: $640
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $245 |
| Vanda Pharmaceuticals Inc. | 3 | $164 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Otsuka America Pharmaceutical, Inc. | 5 | $109 |
Products named: FANAPT, LYBALVI, AUSTEDO XR, ARISTADA, REXULTI, ABILIFY ASIMTUFII, ABILIFY MAINTENA.
Industry payments across CA — which companies pay providers there.
